Journal CME

Volume 91, Number 9, Supplement 1

The RSV roadmap in children: Lessons learned, paths forward

How to Obtain AMA PRA Category 1 Credit

  1. Review information on this page.
  2. Read the supplement article.
  3. Return to this page and select the "Complete the CME Process" link.
  4. Login to your myCME account.
  5. Complete the registration/evaluation form.
  6. Print your personalized CME certificate.

Release Date: September 1, 2024
Expiration Date: August 31, 2026

Estimated Time of Completion: 30 minutes

Description

This article reviews the significant threat of respiratory syncytial virus (RSV) to infants globally, causing bronchiolitis and pneumonia. It covers the challenges faced in vaccine development, past attempts causing enhanced disease, and the recent advancements in maternal vaccines and monoclonal antibodies that show significant benefits in preventing severe RSV-related illness in infants.

Learning Objectives

  1. Describe the burden of RSV infection in children and its impact on healthcare systems.
  2. Review the history and challenges of RSV vaccine development, and the recent breakthroughs and innovations in RSV prevention.
  3. Explore the benefits of the new RSV vaccines and monoclonal antibody prophylaxis in preventing severe RSV-related illness in infants.

Target Audience

This educational activity is designed for geriatricians, infectious disease physicians, intensivists, nurse practitioners, nurses, obstetricians/gynecologists, pediatricians, pharmacists, physician assistants, primary care physicians, pulmonologists, and other prescribing and non-prescribing providers.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation 

American Medical Association (AMA)

Cleveland Clinic Center for Continuing Education designates this journal-based activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

American Nurses Credentialing Center (ANCC)

Cleveland Clinic Center for Continuing Education designates this journal-based activity for a maximum of 0.5 ANCC contact hours.

American Academy of PAs (AAPA)

Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Accreditation Council of Pharmacy Education (ACPE)

Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 0.5 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. Universal Activity Number List:
- Pharmacist UAN: JA0000192-0000-24-474-H06-P

Certificate of Participation

A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.

Planning Committee and Authors

Cecile M. Foshee, PhD
Co-Activity Director;
Director, Office of Interprofessional Learning, Cleveland Clinic

Steven M. Gordon, MD
Co-Activity Director;
Chairman, Infectious Disease Department, Cleveland Clinic

Kaitlyn Rivard, PharmD
Co-Activity Director;
Department of Pharmacy, Cleveland Clinic

Nichole Brown, MSN, RN, CHSE-A, PhD(c)
Nursing Institute, Cleveland Clinic

Neal Chaisson, MD
Department of Critical Care Medicine
and Department of Pulmonary Medicine, Cleveland Clinic

Frank Esper, MD
Pediatric Infectious Disease, Cleveland Clinic Children’s Hospital

Debra Kangisser, PA-C
Director of Education;
Physician Assistant Services, Cleveland Clinic

Aanchal Kapoor, MD, Med
Department of Critical Care Medicine
and Department of Pulmonary Medicine, Cleveland Clinic

Steven Kawczak, PhD, CHCP, FACEHP
Co-Medical Director, Center for Continuing Education, Cleveland Clinic

Neil Mehta, MBBS, MS
Center for Technology-Enhanced Knowledge and Instruction, Cleveland Clinic;
Associate Dean of Curricular Affairs, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University

Anne Vanderbilt, APRN
Senior Director, Advance Nursing Practices Center for Geriatric Medicine, Cleveland Clinic

Hannah Wang, MD
Director, Molecular Microbiology & Virology, Cleveland Clinic

Authors

Ruchita Negi, MD
Center for Pediatric Infectious Diseases, Department of Pediatrics,
Cleveland Clinic Children’s, Cleveland, OH

Jonathan Shabab, MD
Center for Pediatric Infectious Diseases, Department of Pediatrics,
Cleveland Clinic Children’s, Cleveland, OH

Frank Esper, MD
Center for Pediatric Infectious Diseases, Department of Pediatrics,
Cleveland Clinic Children’s, Cleveland, OH;
Associate Professor, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University, Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:

Neal Chaisson, MD
  Teaching and speaking Merck
  Consulting, teaching and speaking United Therapeutics Corporation
  Advisor or review panel participant, teaching and speaking Bayer
Frank Esper, MD
  Advisor or review panel participant Procter & Gamble
Kaitlyn Rivard, PharmD
  Advisor or review panel participant Pfizer
Jonathan Shabab, MD
  Teaching and Speaking Moderna
Hannah Wang, MD
  Research: Cepheid may be providing reagents and financial support for a study on which I am principal investigator. The contract is currently under negotiation. Cepheid
  Research: Hologic is providing reagents for a study in which I am a co-investigator. Hologic

The following faculty have indicated they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Nichole Brown, MSN, BSN
Cecile M. Foshee, PhD
Steven Mark Gordon, MD
Debra Kangisser, PA-C
Aanchal Kapoor, MD
Steven Kawczak, PhD
Neil Mehta, MD
Ruchita Negi, MD
Anne Vanderbilt, APRN


(Article opens in a new tab / window; return to this window to complete the activity).

after completion, claim CME

The Cleveland Clinic Center for Continuing Education acknowledges an educational grant for support of this activity
from ModernaTX, Inc.

This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.